Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $68.00K in the twelve months ending March 31, 2024, down -99.92% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.00K, a -95.38% decrease year-over-year. In the year 2023, Lyell Immunopharma had annual revenue of $130.00K, a decrease of -99.85%.

• Revenue (ttm): $68.00K
• Revenue Growth: -99.92%
• P/S Ratio: 10,178.81
• Revenue / Employee: $304
• Employees: 224
• Market Cap: 692.16M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	130.00K	-84.55M	-99.85%
Dec 31, 2022	84.68M	74.03M	695.15%
Dec 31, 2021	10.65M	2.89M	37.31%
Dec 31, 2020	7.76M	7.10M	1,080.52%
Dec 31, 2019	657.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.